Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 37

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 37
---
— — Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,686 shares at June 30, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,685 shares at June 30, 2025 and 24,517 shares at December 31, 20242,469 2,452 Additional paid-in capital1,435,935 1,412,118 Treasury stock, at cost (43 shares at June 30, 2025 and 571 shares at December 31, 2024)(6)(92)Retained earnings710,020 690,158 Accumulated other comprehensive loss(32,642)(139,401)TOTAL STOCKHOLDERS' EQUITY2,115,776 1,965,235 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,107,389 $4,203,931 

______________________________________________________

(1) December 31, 2024 balances were derived from audited consolidated financial statements.

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share data)

 Three months ended June 30,Six months ended June 30, 2025202420252024TOTAL REVENUES$548,866 $596,455 $1,153,568 $1,163,110 COST OF GOODS SOLD340,802 389,027 735,395 770,438 GROSS PROFIT208,064 207,428 418,173 392,672 OPERATING EXPENSES:  Selling, general and administrative159,392 159,549 316,625 317,206 Research and development21,867 23,390 45,158 45,232 Restructuring, strategic transaction and integration16,218 17,136 32,915 33,241 Change in fair value of contingent earn-out— (339)— (44)TOTAL OPERATING EXPENSES197,477 199,736 394,698 395,635 INCOME (LOSS) FROM OPERATIONS10,587